Comparison of the effects of the 5-HT3 receptor antagonists WAY-100579 and ondansetron on spatial learning in the water maze in rats with excitotoxic lesions of the forebrain cholinergic projection system

Psychopharmacology

Volumn 125, Issue 2, 1996, Pages 146-161

  Hodges, H ^a   Sowinski, P ^a   Turner, J J ^b   Fletcher, A ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF EAST LONDON   (United Kingdom)

^c PFIZER INC   (United States)

Author keywords

5 HT3 receptor antagonists; AMPA( amino 3 hydroxy 4 isoxazole propionicacid) lesions; Forebrain cholinergic projection system; Spatial learning and memory; Water maze

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ARECOLINE; CHOLINE ACETYLTRANSFERASE; EXCITOTOXIN; MUSCARINIC AGENT; ONDANSETRON; SEROTONIN 3 ANTAGONIST; UNCLASSIFIED DRUG; WAY 100579;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN INJURY; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; CONTROLLED STUDY; FOREBRAIN; HISTOLOGY; INTRACEREBRAL DRUG ADMINISTRATION; LEARNING; MAGNOCELLULAR NUCLEUS; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTUM NUCLEUS; SPATIAL MEMORY; SUBCUTANEOUS DRUG ADMINISTRATION;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; ARECOLINE; EXCITATORY AMINO ACID AGONISTS; MALE; MAZE LEARNING; MUSCARINIC AGONISTS; ONDANSETRON; PROSENCEPHALON; QUINOLONES; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN ANTAGONISTS;

EID: 0030011343     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02249414     Document Type: Review

References (58)

1. Arendt T, Bigl V, Arendt A, Tennstedt A (1983) Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease. Acta Neuropathol 61: 101-108
2. Arendt T, Allen Y, Marchbanks R, Schugens MM, Sinden J, Lantos PL, Gray JA (1989) Cholinergic system and memory in the rat: effects of chronic ethanol, embryonic basal forebrain transplants and excitotoxic lesions of the forebrain cholinergic projection system. Neuroscience 33:435-462
3. 3-like receptors. Synapse 10:7-15
4. 3 recognition sites. J Pharm Pharmacol 40:548-551
5. 3H]Zacopride. J Pharm Pharmacol 40:668-672
6. 3 receptors mediate inhibition of acetylcholine release in cortical tissue. Nature 338:762-763
7. Barnes JM, Costall B, Kelly ME, Naylor RJ, Onaivi ES, Tomkins BM, Tyers MB (1989b) GR38032F improves performance in a mouse habituation test and inhibits cholinergic-linked deficits. Br J Pharmacol 98:693P
8. 3 receptor antagonist, on cognition in rodents and primates. Pharmacol Biochem Behav 35:955-962
9. Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408-417
10. Becker RE, Giacobini E (1988) Advances in the therapy of Alzheimer's disease: issues in the study and development of cholinomimetic therapies. In: Giacobini E, Becker R (eds) Current research in Alzheimer therapy: cholinesterase inhibitors. Taylor and Francis, New York, pp 1-11
11. Berger WT (1984) Long term potentiation of hippocampal synaptic activity affects rate of behavioural learning. Science 224:627-630
12. 3 agonists decrease acetylcholine efflux from the cerebral cortex of freely-moving guinea-pigs. Br J Pharmacol 101:448-452
13. 3 receptor antagonist, in two animal models of anxiety. Eur J Pharmacol 218:327-334
14. 3 receptors. Br J Pharmacol 94:397-412
15. 3 receptor antagonist that appears non-competitive in studies in the rat isolated vagus nerve. Br J Pharmacol 113 [Proc Suppl.]:136P
16. 3 receptors. J Neurochem 62: 2254-2261
17. 3 receptor antagonists. Br J Pharmacol 98:636P
18. 3 receptors. Pharmacol Ther 47:181-202
19. Crook T, Lakin M (1991) Effects of ondansetron in age-associated memory impairment. In: Racagni G, Brunello N, Fukuda T (eds) Biological Psychiatry (vol. 2). Elsevier Science Publishers, Amsterdam, pp 888-890
20. Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S (1986) Age-associated memory impairment. Proposed diagnostic criteria and measures of clinical change: report of a National Institute of Health work group. Dev Neuropsychol 2:261-276
21. Domeney AM, Costall B, Gerrard PA, Jones DNC, Naylor RJ, Tyers MB (1991) The effect of ondansetron on cognitive performance in the marmoset. Pharmacol Biochem Behav 38: 169-175
22. Dunnett SB, Everitt BJ, Robbins TW (1991) The basal forebrain-cortical cholinergic projection system: interpreting the functional consequences of excitotoxic lesions. Trends Neurosci 14:494-501
23. El Badawi A, Schenk EA, (1967) Histochemical method for separate, consecutive and simultaneous demonstration of acetyl-cholinesterase and norepinephrine in cryostat sections. J Histochem Cytochem 15:580-588
24. Fonnum F (1975) A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem 24:407-409
25. Francis PT, Webster M-T, Chessell IP, Holmes C, Stratmann GC, Proctor AW, Cross AJ, Green AR, Bowen DM (1993) Neurotransmitters and second messengers in Aging and Alzheimer's disease. Ann NY Acad Sci 695:19-26
26. Givens B, Olton DS (1994) Local modulation of basal forebrain: effects on working and reference memory. J Neurosci 14: 3578-3587
27. 3 receptor antagonists: a critical update on therapeutic potential. Trends Pharm Sci 141:265-270
28. Grigoryan GA, Hodges H, Mitchell SN, Gray JA (1994) Interactions between the effects of propranolol and nicotine on radial maze performance of rats with lesions of the cholinergic forebrain projection system. Behav Pharmacol 5:265-280
29. Harder JA, Kelly ME (1994) Effects of putative cognitive enhancers on a PCPA+scopolamine induced water maze deficit. J Psychopharmacol Abstract Book. BAP/ISBP joint meeting, Cambridge, UK, A13
30. Hepler DJ, Wenk GL, Cribbs BL, Olton DS, Coyle JT (1985) Memory impairments following basal forebrain lesions. Brain Res 346:8-14
31. Hodges H, Allen Y, Sinden J, Lantos PL, Gray JA (1991) Effects of cholinergic-rich neural grafts on radial maze performance of rats after excitotoxic lesions of the forebrain cholinergic projection system-II: cholinergic drugs as probes to investigate lesion-induced deficits and transplant-induced functional recovery. Neuroscience 45:609-623
32. Hodges H, Sinden J, Turner JJ, Netto CA, Sowinski P, Gray JA (1992) Nicotine as a tool to assess the role of the cholinergic forebrain projection system in cognition. In: Collins AC, Gray JA, Robinson JH, Lipiello PM (eds) The biology of nicotine. Raven Press, New York, pp 157-180
33. 3 antagonist, WAY-100289, enhances spatial memory in rats with ibotenate lesions of the forebrain cholinergic projection system. Psychopharmacology 117:318-332
34. 3 receptor ligands lack modulatory influence on acetylcholine release in rat entorhinal cortex. Naunyn-Schmiedeberg's Arch Pharmacol 347:241-247
35. 3 receptors in the rat brain using radioligand binding. Nature 330:746-748
36. Kopelman MD (1986) The cholinergic neurotransmitter system in human memory and dementia: a review. Q J Exp Psychol 38A:535-573
37. 3 receptors on the induction of LTP in mossy fiber-CA3 system of guinea-pig hippocampal slices. Neurosci Res 18: 277-282
38. Mandel RJ, Gage FH, Thai LJ (1989) Enhanced detection of nucleus basalis magnocellularis lesion-induced deficit in rats by modification of training regimen. Behav Brain Res 31:221-229
39. 3 receptors sited on cholinergic axon terminals of human cortex mediate inhibition of acetylcholine release. J Neurochem 58:2334-2337
40. M'Harzi M, Jarrard LE (1992) Effects of medial and lateral septal lesions on acquisition of a place and cue radial maze task. Behav Brain Res 49:159-165
41. Nilsson OG, Leanza G, Bjorklund A (1992a) Acetylcholine release in the hippocampus: regulation by monoaminergic afferents as assessed by in vivo microdialysis. Brain Res 584:132-140
42. Nilsson OG, Leanza G, Rosenblad C, Lappi DA, Wiley RG, Bjorklund A (1992b) Spatial learning impairments in rats with selective immunolesion of the forebrain cholinergic system. Neuro Report 3:1005-1008
43. Ohne T, Koshimura K, Akiyama Y, Ito A, Kido T, Takagi Y, Miwa S (1992) Regulation of acetylcholine release in vivo from rat hippocampus by monoamines as revealed by novel column-switching HPLC with electrochemical detection. Brain Res 572:340-344
44. Page KJ, Everitt BJ, Robbins TW, Marston HM, Wilkinson LS (1991) Dissociable effects on spatial maze and passive avoidance acquisition and retention following AMPA- and ibotenic acid-induced excitotoxic lesions of the basal forebrain in rats: differential dependence on cholinergic neuronal loss. Neuroscience 43:457-472
45. Parkins KL, Cheng CHK, Costall B, Naylor RJ (1994) Effect of ondansetron on acetylcholine release from the hippocampus of aged and young rats. J Psychopharmacol Abstract Book: BAP/ISBP joint meeting, Cambridge, UK, A14
46. 3) antagonists, on electrophysiological properties of the rat hippocampus. Br J Pharmacol 112:695-703
47. 3 receptor antagonist GR68755 on scopolamine-induced cognitive deficit in healthy subjects. Br J Clin Pharmacol 33:546P
48. Robinson SE (1983) Effect of specific serotonergic lesions on cholinergic neurons in the hippocampus, cortex and striatum. Life Sci 32:345-353
49. 3 antagonists ondansetron and BRL 46470 do not facilitate learning of the water maze. J Psychopharmacol Abstract Book: BAP/ISBP joint meeting, Cambridge, UK, A12
50. 3 antagonists on learning in the common marmoset. J Psychopharmacol Abstract Book: BAP/ISBP joint meeting, Cambridge, UK, A43
51. 3 receptor antagonists on hippocampal theta rhythm, memory and long term potentiation induction in freely moving rats. J Neurosci 15: 2445-2452
52. Turner JJ, Hodges H, Sinden JD, Gray JA (1992) Comparison of radial maze performance of rats after ibotenate and quisqualate lesions of the forebrain cholinergic projection system: effects of pharmacological challenge and changes in training regime. Behav Pharmacol 3:359-373
53. 3 receptors. Ann NY Acad Sci 600:194-205
54. Vizi ES, Harsing LG, Zsilla G (1981) Evidence of the modulatory role of serotonin on acetylcholine release from striatal interneurones. Brain Res 212:89-99
55. 3 receptors in the mouse CNS. Eur J Pharmacol 151:351-352
56. 3[H]ICS 205 930. Neuroscience 31:393-400
57. Winson J (1978) Loss of hippocampal theta rhythm results in spatial deficit in the rat. Science 201:160-163
58. Woolf NJ (1991) Cholinergic systems in mammalian brain and spinal cord. Prog Neurobiol 37:475-524